ERK activity in mutant BRAF melanoma - A live report

被引：0
|
作者：
Aplin, Andrew E. [1 ]
机构：
[1] Thomas Jefferson Univ, Kimmel Canc Ctr, Philadelphia, PA 19107 USA
来源：
CLINICAL CANCER RESEARCH | 2015年 / 21卷
关键词：
D O I：
10.1158/1557-3265.PMS14-IA18
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
IA18
引用
收藏
页数：1
相关论文
共 50 条
  • [31] ERK-mediated phosphorylation regulates SOX10 sumoylation and targets expression in mutant BRAF melanoma
    Shujun Han
    Yibo Ren
    Wangxiao He
    Huadong Liu
    Zhe Zhi
    Xinliang Zhu
    Tielin Yang
    Yu Rong
    Bohan Ma
    Timothy J. Purwin
    Zhenlin Ouyang
    Caixia Li
    Xun Wang
    Xueqiang Wang
    Huizi Yang
    Yan Zheng
    Andrew E. Aplin
    Jiankang Liu
    Yongping Shao
    Nature Communications, 9
  • [32] Bowel perforation associated with robust response to BRAF/MEK inhibitor therapy for BRAF-mutant melanoma: a case report
    Kass, Samantha L.
    Linden, Allison F.
    Jackson, Patrick G.
    De Brito, Pedro A.
    Atkins, Michael B.
    MELANOMA MANAGEMENT, 2015, 2 (02) : 115 - 120
  • [33] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    Aya, F.
    Fernandez-Martinez, A.
    Gaba, L.
    Victoria, I.
    Tosca, M.
    Pineda, E.
    Gascon, P.
    Prat, A.
    Arance, A.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2017, 19 (01): : 119 - 124
  • [34] BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
    Liu, Qi
    Zhu, Hongda
    Liu, Yun
    Musetti, Sara
    Huang, Leaf
    CANCER IMMUNOLOGY IMMUNOTHERAPY, 2018, 67 (02) : 299 - 310
  • [35] Sequential treatment with immunotherapy and BRAF inhibitors in BRAF-mutant advanced melanoma
    F. Aya
    A. Fernandez-Martinez
    L. Gaba
    I. Victoria
    M. Tosca
    E. Pineda
    P. Gascon
    A. Prat
    A. Arance
    Clinical and Translational Oncology, 2017, 19 : 119 - 124
  • [36] BRAF peptide vaccine facilitates therapy of murine BRAF-mutant melanoma
    Qi Liu
    Hongda Zhu
    Yun Liu
    Sara Musetti
    Leaf Huang
    Cancer Immunology, Immunotherapy, 2018, 67 : 299 - 310
  • [37] BRAF inhibitors: efficacious and tolerable in BRAF-mutant acral and mucosal melanoma
    Bai, X.
    Mao, L. L.
    Chi, Z. H.
    Sheng, X. N.
    Gui, C. L.
    Kong, Y.
    Dai, J.
    Wang, X.
    Li, S. M.
    Tang, B. X.
    Lian, B.
    Zhou, L.
    Yan, X. Q.
    Guo, J.
    Si, L.
    NEOPLASMA, 2017, 64 (04) : 626 - 632
  • [38] BET and BRAF inhibitors act synergistically against BRAF-mutant melanoma
    Paoluzzi, Luca
    Hanniford, Douglas
    Sokolova, Elena
    Osman, Iman
    Darvishian, Farbod
    Wang, Jinhua
    Bradner, James E.
    Hernando, Eva
    CANCER MEDICINE, 2016, 5 (06): : 1183 - 1193
  • [39] Current Advances in the Treatment of BRAF-Mutant Melanoma
    Patel, Hima
    Yacoub, Nour
    Mishra, Rosalin
    White, Aaron
    Yuan, Long
    Alanazi, Samar
    Garrett, Joan T.
    CANCERS, 2020, 12 (02)
  • [40] Drug Combos Validated in BRAF-Mutant Melanoma
    不详
    CANCER DISCOVERY, 2014, 4 (12) : 1361 - 1362
12345